Piklu Mallick

Piklu Mallick

Auto-generated profile, based on publicly available information

Piklu Mallick

Max Planck Institute for Dynamics and Self-Organization

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LMLaura Müller
Laura Müller
PMPiklu Mallick
Piklu Mallick
AMAntonio B. Marín-Carballo
Antonio B. Marín-Carballo
PDPhilipp Dönges
Philipp Dönges
RKRobyn J. N. Kettlitz
Robyn J. N. Kettlitz
SCSeba Contreras
Seba Contreras
HIV pre-exposure prophylaxis (PrEP) is transforming global HIV prevention, but its implementation coincides with observations of rising bacterial sexually transmitted infection (STI) rates among men who have sex with men, raising questions about whether PrEP is preventing one epidemic while facilitating others. To reconcile this apparent contradiction, we developed a minimal dynamical model of the simultaneous transmission of HIV and chlamydia (as an example of a curable STI). The model integrates three key mechanisms: 1) risk-mediated self-protective behavior, 2) reduction in condom use among PrEP users, and 3) PrEP-related asymptomatic STI screening. We show that these mechanisms can generate a “testing paradox:” True STI prevalence may decline while observed trends rise. This paradox emerges because increased PrEP uptake amplifies screening intensity, which can lower transmission but simultaneously inflate detection. By systematically mapping the parameter space of PrEP uptake, screening frequency, and risk perception, we identify broad and plausible conditions under which the paradox arises. Our findings reconcile conflicting epidemiological evidence and remark that the net effect of PrEP on STI dynamics depends critically on asymptomatic screening strategies. These results highlight the potential dual role of PrEP programs in reducing both HIV and bacterial STI incidence, while emphasizing the need to align screening and treatment policies to maximize benefits and minimize risks, e.g., antimicrobial resistance.

19 June 2026 in Chaos, Solitons & Fractals
Verified
Journal Article
Open access
PMPiklu Mallick
Piklu Mallick
LMLaura Müller
Laura Müller
AMAntonio B. Marín-Carballo
Antonio B. Marín-Carballo
PDPhilipp Dönges
Philipp Dönges
SCSeba Contreras
Seba Contreras

31 July 2026 in eClinicalMedicine
Verified
Journal Article
Open access
SCSeba Contreras
Seba Contreras
PDPhilipp Dönges
Philipp Dönges
LMLaura Müller
Laura Müller
PMPiklu Mallick
Piklu Mallick
SPSydney Paltra
Sydney Paltra
VPViola Priesemann
Viola Priesemann